Listed

AIM ImmunoTech Inc.

AIMNYSECIK 946644HealthcareFiscal year ends Dec 31

Reports and events: 417 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

AIM ImmunoTech Inc., Reports and events
FiledFormWhat it isAccession number
2023-08-1417:03 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-028610
2023-08-0716:15 ETSC 13D/AOwnership report, active investor, amended0001193125-23-204985
2023-07-2717:01 ETSC 13DOwnership report, active investor0001193125-23-196184
2023-07-1016:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-024125
2023-06-2714:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-022594
2023-05-3007:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-019393
2023-05-1518:30 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-016763
2023-04-1916:45 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-012921
2023-04-0716:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-011560
2023-03-3116:42 ET10-KAnnual reportPeriod 2022-12-310001493152-23-010351
2023-03-3008:50 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-009606
2023-03-1608:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-007841
2023-03-1308:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-007353
2023-03-0808:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-006977
2023-03-0608:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-006744
2023-02-2415:06 ET8-K7.01 Regulation FD disclosure0001493152-23-005961
2023-02-1016:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-004312
2023-02-0607:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-003624
2023-01-1708:50 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-001536
2022-11-1416:34 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-032118
2022-11-0908:45 ET8-K5.07 Shareholder vote results0001493152-22-031043
2022-09-0916:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-025491
2022-08-1508:00 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-022600
2022-07-1808:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-019534
2022-06-2108:35 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-017273
2022-06-1709:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-017052
2022-05-1316:32 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-013341
2022-04-1207:47 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-009656
2022-03-3113:05 ET10-KAnnual reportPeriod 2021-12-310001493152-22-008324
2022-03-2808:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-007813
2022-03-1607:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-006933
2022-03-0708:05 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-006141
2022-03-0308:35 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-005894
2022-01-2713:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-002382
2022-01-2609:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-002248
2022-01-2408:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-002053
2021-12-0907:20 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-030891
2021-11-1516:34 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-028650
2021-10-0717:15 ET8-K5.07 Shareholder vote results0001493152-21-024968
2021-10-0607:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-024737
2021-09-3006:11 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-21-024139
2021-09-2116:30 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-023270
2021-09-1707:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-022966
2021-08-1716:30 ET10-Q/AQuarterly report, amendedPeriod 2021-06-300001493152-21-020453
2021-08-1716:30 ETDEF 14AProxy statementPeriod 2021-08-170001493152-21-020454
2021-08-1616:51 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-020230
2021-07-1410:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-016808
2021-07-1308:00 ET8-K1.01 Entry into a material agreement0001493152-21-016676
2021-06-1407:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-014224
2021-05-2708:45 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-013029

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:22 ET. Listed shows no prices and gives no investment advice.